QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Dalia, A. Articles by Hadjiconstantinou, M. Search for Related Content PubMed PubMed Citation Articles by Dalia, A. Articles by Hadjiconstantinou, M.

 Previous Article  |  Next Article 

Journal of Neuroscience, Vol 13, 3104-3111, Copyright © 1993 by Society for Neuroscience

ARTICLE

GM1 ganglioside improves dopaminergic markers of rat mesencephalic cultures treated with MPP+

A Dalia, NH Neff and M Hadjiconstantinou
Department of Pharmacology, Ohio State University College of Medicine, Columbus 43210.

Rat embryonic mesencephalic cultures were employed to evaluate the consequences of adding GM1 ganglioside to cultures lesioned with the selective neurotoxin 1-methyl-4-phenylpyridinium (MPP+). MPP+ reduced dopamine and DOPAC content, dopamine uptake, aromatic L-amino acid decarboxylase activity, and the number of tyrosine hydroxylase- immunopositive neurons. The immunopositive neurons that remained were aberrant. All of these parameters were partially restored by adding GM1 ganglioside to the cultures. The response to GM1 was not altered by prior treatment of the cultures with cytosine beta-D-arabinofuranoside to reduce the number of glial cells. Dopamine uptake activity restored by GM1 was lost if GM1 was removed from the culture.

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help